Literature DB >> 10908648

The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

A Borkhardt1, S Bojesen, O A Haas, U Fuchs, D Bartelheimer, I F Loncarevic, R M Bohle, J Harbott, R Repp, U Jaeger, S Viehmann, T Henn, P Korth, D Scharr, F Lampert.   

Abstract

We have isolated the human GRAF gene (for GTPase regulator associated with the focal adhesion kinase pp125(FAK)). This gene was fused with MLL in a unique t(5;11)(q31;q23) that occurred in an infant with juvenile myelomonocytic leukemia. GRAF encodes a member of the Rho family of the GTPase-activating protein (GAP) family. On the protein level, it is 90% homologous to the recently described chicken GRAF gene that functions as a GAP of RhoA in vivo and is thus a critical component of the integrin signaling transduction pathway. The particular position of the human GRAF gene at 5q31 and the proposed antiproliferative and tumor suppressor properties of its avian homologue suggest that it also might be pathogenetically relevant for hematologic malignancies with deletions of 5q. To investigate this possibility, we sequenced 4-5 individual cDNA clones from 13 cases in which one allele of GRAF was deleted. We found point mutations within the GAP domain of the second GRAF allele in one patient. In two additional patients we found an insertion of 52 or 74 bp within the GRAF cDNA that generates a reading frame shift followed by a premature stop codon. GRAF maps outside the previously defined commonly deleted 5q31 region. Nevertheless, inactivation of both alleles in at least some cases suggests that deletions and mutations of the GRAF gene may be instrumental in the development and progression of hematopoeitic disorders with a del(5q).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908648      PMCID: PMC16840          DOI: 10.1073/pnas.150079597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The role of chromosome translocations in leukemogenesis.

Authors:  J D Rowley
Journal:  Semin Hematol       Date:  1999-10       Impact factor: 3.851

2.  Long PCR.

Authors:  S Cheng; S Y Chang; P Gravitt; R Respess
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

Review 3.  Tumour suppressor genes in disease and therapy.

Authors:  G R Skuse; J W Ludlow
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

4.  11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.

Authors:  N J Zeleznik-Le; A M Harden; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 5.  The 5q-syndrome.

Authors:  J Boultwood; S Lewis; J S Wainscoat
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

Review 6.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

7.  Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.

Authors:  J Boultwood; C Fidler; S Lewis; S Kelly; H Sheridan; T J Littlewood; V J Buckle; J S Wainscoat
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

8.  Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia.

Authors:  Y Gu; H Alder; T Nakamura; S A Schichman; R Prasad; O Canaani; H Saito; C M Croce; E Canaani
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

9.  Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridization with a yeast artificial chromosome.

Authors:  L Kearney; M Bower; B Gibbons; S Das; T Chaplin; E Nacheva; J M Chessells; B Reeves; J H Riley; T A Lister
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

10.  Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis.

Authors:  R Repp; A Borkhardt; E Haupt; J Kreuder; S Brettreich; J Hammermann; K Nishida; J Harbott; F Lampert
Journal:  Leukemia       Date:  1995-01       Impact factor: 11.528

View more
  32 in total

Review 1.  JMML genomics and decisions.

Authors:  Charlotte M Niemeyer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.

Authors:  Tanja Andrea Gruber; Mi Sook Chang; Richard Sposto; Markus Müschen
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

3.  The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.

Authors:  U Fuchs; G Rehkamp; O A Haas; R Slany; M Kōnig; S Bojesen; R M Bohle; C Damm-Welk; W D Ludwig; J Harbott; A Borkhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.

Authors:  Ting Xi Liu; Yi Zhou; John P Kanki; Min Deng; Jennifer Rhodes; Hong Wei Yang; Xiao Ming Sheng; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 5.  Important features of myelodysplastic syndrome.

Authors:  Wolf K Hofmann; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures.

Authors:  C L Bennett; H M Huynh; P F Chance; I A Glass; S M Gospe
Journal:  Neurogenetics       Date:  2005-08-02       Impact factor: 2.660

Review 7.  Rho GTPases in hematopoiesis and hemopathies.

Authors:  James C Mulloy; Jose A Cancelas; Marie-Dominique Filippi; Theodosia A Kalfa; Fukun Guo; Yi Zheng
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

8.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

9.  Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.

Authors:  Vincenza Barresi; Angela Ragusa; Marco Fichera; Nicolò Musso; Lucia Castiglia; Giancarlo Rappazzo; Salvatore Travali; Teresa Mattina; Corrado Romano; Guido Cocchi; Daniele F Condorelli
Journal:  BMC Med Genomics       Date:  2010-07-06       Impact factor: 3.063

10.  Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.

Authors:  Judith Barrios; Robert Wieder
Journal:  Cancer Microenviron       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.